Revvity Inc at Raymond James Institutional Investors Conference Transcript
Good morning, everyone. I'm Andrew Cooper, the Life Science Tools and Diagnostics analyst here at Raymond James. Happy to be joined by the team from Revvity. We're going to do a little bit of presentation and then have some fireside chat as well. So with that, I'm going to pass it right over to Max, Chief Financial Officer and take it away.
Thanks, Andrew. And I appreciate you having us here. And for those of us that haven't followed Revvity as closely over the past year, there's been a ton of change that has happened. And so hopefully, today, we'll spend the next 10 minutes kind of giving you a high-level overview of that transformation and why we're so excited about the future of our company. I'd encourage you to read our safe harbor statement. You can also find additional disclosures on our website for any forward-looking statements that we'll make for today.
So a question of what is Revvity? So I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
